XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 600,000 | $20,496,000 | 1.09% |
| Rock Springs Capital Management LP | 1,178,002 | $40,240,548 | 1.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 91,500 | $3,121,980 | 1.05% |
| Polar Capital Holdings Plc | 3,003,747 | $102,607,998 | 0.76% |
| Perceptive Advisors | 617,500 | $21,093,800 | 0.70% |
| Orbimed Advisors | 958,793 | $32,752,369 | 0.70% |
| Redmile Group, LLC | 419,568 | $14,332,443 | 0.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 53,996 | $1,844,503 | 0.56% |
| HighVista Strategies LLC | 35,255 | $1,204,311 | 0.56% |
| SAMLYN CAPITAL, LLC | 951,755 | $32,511,951 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 82,400 | $2,814,784 | 0.51% |
| Avidity Partners Management LP | 321,400 | $10,979,024 | 0.44% |
| TimesSquare Capital Management, LLC | 590,575 | $20,174 | 0.31% |
| Knott David M Jr | 23,866 | $815 | 0.31% |
| Birchview Capital, LP | 10,000 | $341,600 | 0.29% |
| Granahan Investment Management | 236,290 | $8,071,666 | 0.29% |
| Eventide Asset Management | 413,906 | $14,139,029 | 0.25% |
| SPHERA FUNDS MANAGEMENT LTD. | 38,959 | $1,330,839 | 0.24% |
| ALGERT GLOBAL LLC | 128,487 | $4,389 | 0.21% |
| ADVISORY RESEARCH INC | 38,326 | $1,309,217 | 0.18% |
External links
This page lists XENON PHARMACEUTICALS INC's shareholders in Q3 2023. To view XENON PHARMACEUTICALS INC's shareholder history, click here.